17 Capital Partners’s Omnicell OMCL Stock Holding History

17 Capital Partners’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$243K	Hold	2,792	–	–	0.33%	75
2022 Q2	$318K	Hold	2,792	–	–	0.4%	74
2022 Q1	$362K	Hold	2,792	–	–	0.38%	75
2021 Q4	$504K	Hold	2,792	–	–	0.46%	71
2021 Q3	$414K	Buy	2,792 +15	+0.5%	+$2.3K	0.39%	76
2021 Q2	$421K	Buy	+2,777	New	+$387K	0.39%	75

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

17 Capital Partners's OMCL Position: Q3 2022 in Review

17 Capital Partners held its Omnicell (OMCL) position steady in Q3 2022 at 2,792 shares worth $243K. The position accounts for 0.33% of the portfolio, ranked #75.

17 Capital Partners first reported a position in OMCL in Q2 2021 and has held it in 6 quarters since. The position peaked at $504K in Q4 2021. 374 funds tracked by Wall St. Rank hold OMCL as of Q3 2022.

17 Capital Partners held 2,792 shares of Omnicell worth $243K as of Q3 2022.
17 Capital Partners left its Omnicell share count unchanged in Q3 2022.
Omnicell made up 0.33% of 17 Capital Partners's portfolio in Q3 2022, its #75 holding.
17 Capital Partners first reported a position in Omnicell in Q2 2021 and has held it in 6 quarters since.
17 Capital Partners's Omnicell position peaked at $504K in Q4 2021.
374 funds tracked by Wall St. Rank held Omnicell as of Q3 2022.

Based on 17 Capital Partners's 13F filing for Q3 2022, filed 21 Nov 2022.